
Metformin and Long COVID, Central Lines and Thrombocytopenia, DOACs vs LMWH in Cancer Associated Thrombosis, Early vs Late Anticoagulation after Stroke with Atrial Fibrillation
Last Week in Medicine
00:00
Decentralized Trial on Metformin for Long COVID
This chapter discusses a decentralized trial on metformin and its impact on long COVID. The trial randomized participants into different treatment groups and analyzed the outcomes over a period of up to 10 months. The results showed a significant reduction in clinician-diagnosed long COVID for those who received metformin compared to the placebo group.
Play episode from 05:51
Transcript


